These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 20542425

  • 1. Synthesis of isosteric selenium analog of the PPARbeta/delta agonist GW501516 and comparison of biological activity.
    Sharma AK, Sk UH, He P, Peters JM, Amin S.
    Bioorg Med Chem Lett; 2010 Jul 15; 20(14):4050-2. PubMed ID: 20542425
    [Abstract] [Full Text] [Related]

  • 2. The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.
    Barroso E, Eyre E, Palomer X, Vázquez-Carrera M.
    Biochem Pharmacol; 2011 Feb 15; 81(4):534-43. PubMed ID: 21146504
    [Abstract] [Full Text] [Related]

  • 3. Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.
    Borland MG, Foreman JE, Girroir EE, Zolfaghari R, Sharma AK, Amin S, Gonzalez FJ, Ross AC, Peters JM.
    Mol Pharmacol; 2008 Nov 15; 74(5):1429-42. PubMed ID: 18687807
    [Abstract] [Full Text] [Related]

  • 4. Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis.
    Piqueras L, Reynolds AR, Hodivala-Dilke KM, Alfranca A, Redondo JM, Hatae T, Tanabe T, Warner TD, Bishop-Bailey D.
    Arterioscler Thromb Vasc Biol; 2007 Jan 15; 27(1):63-9. PubMed ID: 17068288
    [Abstract] [Full Text] [Related]

  • 5. PPARbeta/delta agonist increases the expression of PGE2 receptor subtype EP4 in human lung carcinoma cells.
    Ritzenthaler JD, Roman J, Han S.
    Methods Mol Biol; 2009 Jan 15; 512():309-23. PubMed ID: 19347285
    [Abstract] [Full Text] [Related]

  • 6. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
    Rieck M, Meissner W, Ries S, Müller-Brüsselbach S, Müller R.
    Mol Pharmacol; 2008 Nov 15; 74(5):1269-77. PubMed ID: 18701617
    [Abstract] [Full Text] [Related]

  • 7. PPARbeta/delta agonists modulate platelet function via a mechanism involving PPAR receptors and specific association/repression of PKCalpha--brief report.
    Ali FY, Hall MG, Desvergne B, Warner TD, Mitchell JA.
    Arterioscler Thromb Vasc Biol; 2009 Nov 15; 29(11):1871-3. PubMed ID: 19696401
    [Abstract] [Full Text] [Related]

  • 8. The role of peroxisome proliferator-activated receptor-beta/delta in epidermal growth factor-induced HaCaT cell proliferation.
    Liang P, Jiang B, Yang X, Xiao X, Huang X, Long J, Zhang P, Zhang M, Xiao M, Xie T, Huang X.
    Exp Cell Res; 2008 Oct 15; 314(17):3142-51. PubMed ID: 18625220
    [Abstract] [Full Text] [Related]

  • 9. Synthesis of the PPARbeta/delta-selective agonist GW501516 and C4-thiazole-substituted analogs.
    Pereira R, Gaudon C, Iglesias B, Germain P, Gronemeyer H, de Lera AR.
    Bioorg Med Chem Lett; 2006 Jan 01; 16(1):49-54. PubMed ID: 16242326
    [Abstract] [Full Text] [Related]

  • 10. 15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor beta/delta agonist.
    Naruhn S, Meissner W, Adhikary T, Kaddatz K, Klein T, Watzer B, Müller-Brüsselbach S, Müller R.
    Mol Pharmacol; 2010 Feb 01; 77(2):171-84. PubMed ID: 19903832
    [Abstract] [Full Text] [Related]

  • 11. PPARbeta/delta activation inhibits angiotensin II-induced collagen type I expression in rat cardiac fibroblasts.
    Zhang H, Pi R, Li R, Wang P, Tang F, Zhou S, Gao J, Jiang J, Chen S, Liu P.
    Arch Biochem Biophys; 2007 Apr 01; 460(1):25-32. PubMed ID: 17346664
    [Abstract] [Full Text] [Related]

  • 12. Neuroprotective efficacy of the peroxisome proliferator-activated receptor delta-selective agonists in vitro and in vivo.
    Iwashita A, Muramatsu Y, Yamazaki T, Muramoto M, Kita Y, Yamazaki S, Mihara K, Moriguchi A, Matsuoka N.
    J Pharmacol Exp Ther; 2007 Mar 01; 320(3):1087-96. PubMed ID: 17167170
    [Abstract] [Full Text] [Related]

  • 13. PPARbeta/delta agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3K and NF-kappaB signals.
    Han S, Ritzenthaler JD, Zheng Y, Roman J.
    Am J Physiol Lung Cell Mol Physiol; 2008 Jun 01; 294(6):L1238-49. PubMed ID: 18390835
    [Abstract] [Full Text] [Related]

  • 14. Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.
    Borland MG, Khozoie C, Albrecht PP, Zhu B, Lee C, Lahoti TS, Gonzalez FJ, Peters JM.
    Cell Signal; 2011 Dec 01; 23(12):2039-50. PubMed ID: 21843636
    [Abstract] [Full Text] [Related]

  • 15. Role of peroxisome proliferator-activated receptor beta/delta in chicken adipogenesis.
    Sato K, Yonemura T, Ishii H, Toyomizu M, Kamada T, Akiba Y.
    Comp Biochem Physiol A Mol Integr Physiol; 2009 Nov 01; 154(3):370-5. PubMed ID: 19619666
    [Abstract] [Full Text] [Related]

  • 16. Expression level and agonist-binding affect the turnover, ubiquitination and complex formation of peroxisome proliferator activated receptor beta.
    Rieck M, Wedeken L, Müller-Brüsselbach S, Meissner W, Müller R.
    FEBS J; 2007 Oct 01; 274(19):5068-76. PubMed ID: 17803688
    [Abstract] [Full Text] [Related]

  • 17. Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line.
    Foreman JE, Sharma AK, Amin S, Gonzalez FJ, Peters JM.
    Cancer Lett; 2010 Feb 28; 288(2):219-25. PubMed ID: 19660859
    [Abstract] [Full Text] [Related]

  • 18. Peroxisome proliferator-activated receptor alpha and gamma ligands differentially affect smooth muscle cell proliferation and migration.
    Zahradka P, Wright B, Fuerst M, Yurkova N, Molnar K, Taylor CG.
    J Pharmacol Exp Ther; 2006 May 28; 317(2):651-9. PubMed ID: 16407462
    [Abstract] [Full Text] [Related]

  • 19. Apoptotic effect of the selective PPARβ/δ agonist GW501516 in invasive bladder cancer cells.
    Péchery A, Fauconnet S, Bittard H, Lascombe I.
    Tumour Biol; 2016 Nov 28; 37(11):14789-14802. PubMed ID: 27638828
    [Abstract] [Full Text] [Related]

  • 20. Activation of peroxisome proliferator-activated receptor beta/delta induces lung cancer growth via peroxisome proliferator-activated receptor coactivator gamma-1alpha.
    Han S, Ritzenthaler JD, Sun X, Zheng Y, Roman J.
    Am J Respir Cell Mol Biol; 2009 Mar 28; 40(3):325-31. PubMed ID: 18776129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.